\- • Subjects were able to give informed consent prior to commencing any trial-related assessments or procedures.
Subjects were at least 20 years old when they signed the informed consent form.
At the time of inclusion in this trial, subjects had to have a diagnosis of chronic psoriasis by a dermatologist.
According to Taiwan's regulations and payment policies, subjects will or have received treatment related to psoriasis. Before being included in the trial, physicians will independently determine the course of treatment with western medicine related to psoriasis.
The subjects can communicate well with the trial host and understand the contents of the trial case, and follow the trial specifications.
At the start of the trial, subjects were willing to provide a three-month trial follow-up to record psoriasis severity and dermatological quality of life questionnaires.
You may not be if
The subject is unwilling or unable to comply with the requirements of the trial.
Subject participated in an interventional clinical trial at this time or within the past 30 days. However, participation in another PMOS (post-marketing observational trial) or registration trial is acceptable.
Those who are judged by physicians to be infirm, allergic, cold, chronic disease, poor renal function, children under the age of three, children, pregnant, breastfeeding, menstrual period are not suitable to participate in this research.
